The Science Behind ManukaMed for Effective Wound Care Treatments
Bioactive and Consistent Honey Product
Clinicians struggle to find reliable, effective advanced treatment options for the more than 7 million patients in need of wound care treatment – many of whom are also suffering from complex, comorbid diseases and are at risk of lower extremity amputation. In response to the surprising variation in wound care clinical processes and lack of proven best practices, ManukaMed is committed to sharing its scientifically proven solutions for healing wounds, even in their most complex stages, around the world.
ManukaMed Promotes Lower pH in Wound Bed, Optimal for Wound Healing
Higher MGO concentration in medical grade honey wound care products promotes faster, better healing in wound beds, requiring a lower pH level for optimizing the healing process. According to Molan Gold Standard (MGS), ManukaMed demonstrated the highest MGS levels and the lower pH in the wound bed compared with other commercial Manuka honey products. Medical grade honey requires a 10+ MGS. Optimal pH levels in the wound bed range from 3.5-4.2.1
ManukaMed Increases Plasmin Activity and Osmotic Action for Autolytic Debridement
ManukaMed brand honey is tested and certified by an accredited laboratory under the ISO 17025:2005 standard.
Through ManukaMed’s rigorous lab production standards and quality bioactive testing (QBT), our patented blend of medical grade honey promotes unparalleled chemical synergies for lowering pH and is scientifically proven to have superior, consistent wound healing properties. Impregnated into the super absorbent gelling fiber of our wound dressings, our products demonstrate faster, better results, setting ManukaMed apart from traditional products and leading to thousands of clinical success stories around the world. ManukaMed researchers and scientists work closely with board certified physicians and wound healing specialists to help advance and standardize clinical protocols for the use of our wound care products.
The Power of Manuka Medical Grade Honey
Founding father of Manuka honey science Dr. Peter Molan reported the efficacy of Manuka honey in wound healing across 17 randomized controlled trials involving 1,965 patients. In addition, Molan’s body of research includes positive findings from five clinical trials, 10 multiple case studies, 35 single case studies and 16 animal trials. The evidence continues to grow as increasing numbers of patients dealing with non-healing wounds are responding to ManukaMed products who have not responded to traditional products.
ManukaMed, founded by research scientist Denis Watson and influenced by Dr. Molan, was developed with the vision to heal patients around the world who suffer from chronic wounds. Its parent company is based in New Zealand, and in collaboration with dozens of landowners across the island, is responsible for the exclusive monofloral sourcing and production of ManukaMed’s medical grade honey or Leptospermum scoparium (LS). With access to more than 30,000 bee hives owned by the parent company Watson & Son, ManukaMed scientists are able to use the uniquely potent, highest quality Manuka honey, originating from the nectar of the indigenous Manuka tree flower.
1Gethin, G, Cowman, S and Conroy, R, The impact of Manuka honey dressings on the surface pH of chronic wounds. International Wound Journal, 2008. 5(2): p. 185-194
2 P. Molan; International Journal of Lower Extremity Wounds, 5(1) 2006